Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP304081.RA_v6tw0zxBe-fd2j8QyHFhO8dZAbSFKN-tqwEQ5PU4Wk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP304081.RA_v6tw0zxBe-fd2j8QyHFhO8dZAbSFKN-tqwEQ5PU4Wk130_assertion type Assertion NP304081.RA_v6tw0zxBe-fd2j8QyHFhO8dZAbSFKN-tqwEQ5PU4Wk130_head.
- NP304081.RA_v6tw0zxBe-fd2j8QyHFhO8dZAbSFKN-tqwEQ5PU4Wk130_assertion description "[Recently, we reported that carbamylated erythropoietin (CEPO) protected kidneys from ischemia reperfusion injury as well as EPO.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304081.RA_v6tw0zxBe-fd2j8QyHFhO8dZAbSFKN-tqwEQ5PU4Wk130_provenance.
- NP304081.RA_v6tw0zxBe-fd2j8QyHFhO8dZAbSFKN-tqwEQ5PU4Wk130_assertion evidence source_evidence_literature NP304081.RA_v6tw0zxBe-fd2j8QyHFhO8dZAbSFKN-tqwEQ5PU4Wk130_provenance.
- NP304081.RA_v6tw0zxBe-fd2j8QyHFhO8dZAbSFKN-tqwEQ5PU4Wk130_assertion SIO_000772 22410315 NP304081.RA_v6tw0zxBe-fd2j8QyHFhO8dZAbSFKN-tqwEQ5PU4Wk130_provenance.
- NP304081.RA_v6tw0zxBe-fd2j8QyHFhO8dZAbSFKN-tqwEQ5PU4Wk130_assertion wasDerivedFrom befree-20140225 NP304081.RA_v6tw0zxBe-fd2j8QyHFhO8dZAbSFKN-tqwEQ5PU4Wk130_provenance.
- NP304081.RA_v6tw0zxBe-fd2j8QyHFhO8dZAbSFKN-tqwEQ5PU4Wk130_assertion wasGeneratedBy ECO_0000203 NP304081.RA_v6tw0zxBe-fd2j8QyHFhO8dZAbSFKN-tqwEQ5PU4Wk130_provenance.